Estimating the transfusion risk following total knee arthroplasty. (avaa uuden ikkunan)

Ahmed I, Chan JK, Jenkins P, Brenkel I, Walmsley P.

Lähde‎: Orthopedics 2012;35(10):e1465-71.

Arkistoitu‎: PubMed 23027481

DOI‎: 10.3928/01477447-20120919-13

https://www.ncbi.nlm.nih.gov/pubmed/23027481 (avaa uuden ikkunan)

Ginkgo biloba: persistent bleeding after total hip arthroplasty caused by herbal self-medication. (avaa uuden ikkunan)

Bebbington A, Kulkarni R, Roberts P.

Lähde‎: J Arthroplasty 2005;20(1):125-6.

Arkistoitu‎: PubMed 15660071

DOI‎: 10.1016/j.arth.2004.02.031

https://www.ncbi.nlm.nih.gov/pubmed/15660071 (avaa uuden ikkunan)

Factors affecting transfusion requirement after hip fracture: can we reduce the need for blood? (avaa uuden ikkunan)

Desai SJ, Wood KS, Marsh J, Bryant D, Abdo H, Lawendy AR, Sanders DW.

Lähde‎: Can J Surg 2014;57(5):342-8.

Arkistoitu‎: PubMed 25265109

https://www.ncbi.nlm.nih.gov/pubmed/25265109 (avaa uuden ikkunan)

Multicentre cohort study of red blood cell use for revision hip arthroplasty and factors associated with greater risk of allogeneic blood transfusion. (avaa uuden ikkunan)

Walsh TS, Palmer J, Watson D, Biggin K, Seretny M, Davidson H, Harkness M, Hay A.

Lähde‎: Br J Anaesth 2012;108(1):63-71.

Arkistoitu‎: PubMed 22037224

DOI‎: 10.1093/bja/aer326

https://www.ncbi.nlm.nih.gov/pubmed/22037224 (avaa uuden ikkunan)